School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China; Department of Anesthesiology, the Second Affiliated Hospital of Nantong University, Nantong City 226000, China; Department of Anesthesiology, the First People's Hospital of Nantong, Nantong City 226000, China.
School of Anesthesiology, Xuzhou Medical University, Xuzhou City 221000, China.
Lung Cancer. 2024 Aug;194:107888. doi: 10.1016/j.lungcan.2024.107888. Epub 2024 Jul 9.
To investigate the effects of pregabalin combined with tramadol/paracetamol on acute pain in patients with CT-guided puncture localization of pulmonary nodules.
In this randomized, placebo-controlled and single-center study, 120 patients were allocated randomly to four groups: the control group (Group P), the pregabalin-placebo group (Group BP), the tramadol/paracetamol-placebo group (Group AP), and the pregabalin-tramadol/paracetamol group (Group AB). The primary outcome was the NRS (Numerical Rating Scale) score. Other outcomes included systolic blood pressure (SBP), diastolic blood pressure (DBP), heart rate (HR), pulse oxygen saturation (SpO), the incidence of moderate to severe pain, the analgesia recovery ratio, the incidence of adverse drug reactions and patients' satisfaction.
No significant interaction was detected between the interventions (P = 0.752). The NRS score of the Taking pregabalin group and the Taking tramadol/paracetamol group were significantly lower than those of the Not-taking pregabalin group and the Not-taking tramadol/paracetamol group respectively (P < 0.05). There was significant difference in the NRS scores among the four groups (P < 0.001). The NRS score of Group AB was significantly lower than that of Group P (P < 0.001), Group BP (P < 0.001) and Group AP (P = 0.001). At the same time, the NRS scores of Group BP (P < 0.001) and Group AP (P < 0.001) were significantly lower than those of Group P, but there was no significant difference between Group BP and Group AP (P = 1.000). The SBP, DBP, HR, the incidence of moderate to severe pain and the analgesia recovery ratio of Group AB were significantly lower than those of Group P (P < 0.05), while the SpO and the number of people who were very satisfied were significantly higher than those of Group P (P < 0.05). There was no significant difference in the incidence of adverse drug reactions among the four groups (P = 0.272).
The combination or single use of pregabalin and tramadol/paracetamol can effectively relieve the acute pain after localization. Pregabalin combined with tramadol/paracetamol has the best analgesic effect and significantly reduces the hemodynamic fluctuations, with high safety and low incidence of adverse drug reactions, which has a certain clinical popularization and application value.
观察普瑞巴林联合曲马多/对乙酰氨基酚用于 CT 引导下肺结节穿刺定位术急性疼痛的效果。
这是一项随机、安慰剂对照、单中心研究,共纳入 120 例患者,随机分为 4 组:对照组(P 组)、普瑞巴林安慰剂组(BP 组)、曲马多/对乙酰氨基酚安慰剂组(AP 组)、普瑞巴林联合曲马多/对乙酰氨基酚组(AB 组)。主要结局指标为 NRS 评分。其他结局指标包括收缩压(SBP)、舒张压(DBP)、心率(HR)、脉搏血氧饱和度(SpO)、中重度疼痛发生率、镇痛恢复率、不良反应发生率和患者满意度。
干预措施之间无显著交互作用(P=0.752)。普瑞巴林组和曲马多/对乙酰氨基酚组的 NRS 评分明显低于未用普瑞巴林组和未用曲马多/对乙酰氨基酚组(P<0.05)。四组 NRS 评分比较差异有统计学意义(P<0.001)。AB 组的 NRS 评分明显低于 P 组(P<0.001)、BP 组(P<0.001)和 AP 组(P=0.001)。同时,BP 组(P<0.001)和 AP 组(P<0.001)的 NRS 评分明显低于 P 组,但 BP 组与 AP 组之间无显著差异(P=1.000)。AB 组 SBP、DBP、HR、中重度疼痛发生率及镇痛恢复率明显低于 P 组(P<0.05),而 SpO 和非常满意的人数明显高于 P 组(P<0.05)。四组不良反应发生率比较差异无统计学意义(P=0.272)。
普瑞巴林联合或单独使用曲马多/对乙酰氨基酚可有效缓解定位后急性疼痛。普瑞巴林联合曲马多/对乙酰氨基酚镇痛效果最佳,且显著降低血流动力学波动,安全性高,不良反应发生率低,具有一定的临床推广应用价值。